What is the appropriate dose of the medication for my condition?

Appropriate Medication Dosing for Your Condition

Critical Dosing Principles in Renal Impairment

For patients with chronic kidney disease or end-stage renal disease on hemodialysis, the fundamental dosing strategy is to maintain the full individual dose while extending the dosing interval—never reduce the dose size, as this produces subtherapeutic peak concentrations and treatment failure. 1

Renal Function Assessment

Before any dose adjustment, calculate creatinine clearance using the Cockcroft-Gault formula, as this remains the standard for dosing decisions despite its limitations. 2 For patients on hemodialysis, assume creatinine clearance <10 mL/min. 1

Medication-Specific Dosing Adjustments

Antibiotics for Infection

Beta-Lactams (Cephalexin, Amoxicillin, Cefazolin)

• Creatinine clearance 10–50 mL/min: Reduce frequency to every 12–24 hours while maintaining individual dose strength 1
• Hemodialysis patients: Administer full dose immediately after each dialysis session (typically 3 times weekly) 1, 3
• Example: Cephalexin 500 mg after each dialysis session rather than 500 mg four times daily 3

Fluoroquinolones (Ciprofloxacin, Levofloxacin)

• Ciprofloxacin for hemodialysis: 500 mg orally after each dialysis session (3 times weekly) 1, 3, 4
• Levofloxacin for hemodialysis: 750 mg orally after each dialysis session (3 times weekly) 1, 3, 4
• Creatinine clearance 50–80 mL/min: Levofloxacin 500 mg loading dose, then 250 mg every 24 hours 1
• Creatinine clearance <50 mL/min: Levofloxacin 500 mg loading dose, then 250 mg every 48 hours 1

Vancomycin

• Hemodialysis patients: Loading dose 15–20 mg/kg (approximately 1000–1500 mg) IV after first dialysis, then 500–1000 mg IV after each subsequent dialysis session 4
• Target pre-dialysis trough: 10–25 mcg/mL, measured before the 3rd or 4th dose 4

Aminoglycosides (Amikacin, Streptomycin)

• Creatinine clearance 10–50 mL/min: Maintain 12–15 mg/kg per dose but reduce frequency to 2–3 times weekly 1
• Hemodialysis patients: 12–15 mg/kg after dialysis, 2–3 times weekly 1
• Critical: Monitor serum drug concentrations to avoid ototoxicity and nephrotoxicity 1
• Target peaks: Daily dosing 35–45 μg/mL; intermittent dosing 65–80 μg/mL; trough <5 mg/L 1

Trimethoprim-Sulfamethoxazole

• Creatinine clearance 15–30 mL/min: Reduce dose by 50% 1
• Creatinine clearance <15 mL/min: Reduce dose by 50% or use alternative agent 1
• For Pneumocystis pneumonia treatment:
  • Creatinine clearance 10–50 mL/min: 3–5 mg/kg (as trimethoprim) every 12 hours 1
  • Creatinine clearance <10 mL/min: 3–5 mg/kg every 24 hours 1

Other Antimicrobials

• Clarithromycin: Reduce dose by 50% or double interval if creatinine clearance <30 mL/min 1
• Rifampin: Use 50–100% of full dose regardless of renal function; no supplement needed after hemodialysis 1
• Isoniazid: Standard 300 mg daily; give additional dose after dialysis 1

Antiviral Medications

Acyclovir and Derivatives

• Valacyclovir for creatinine clearance <30 mL/min: 500 mg every 24–48 hours 1
• Famciclovir: Requires dose adjustment based on creatinine clearance (specific adjustments in drug label) 1
• Ganciclovir/Valganciclovir:
  • Creatinine clearance 40–59 mL/min: Valganciclovir 450 mg daily 1
  • Creatinine clearance 25–39 mL/min: Valganciclovir 450 mg daily 1
  • Creatinine clearance 10–24 mL/min: Valganciclovir 450 mg twice weekly 1
  • Creatinine clearance <10 mL/min or hemodialysis: Not recommended 1

Foscarnet

• Requires complex dose adjustment based on creatinine clearance; consult specialized dosing tables 1

Cardiovascular Medications (Heart Failure)

ACE Inhibitors

• Lisinopril: Target dose 20 mg daily; start 2.5–5 mg once daily and titrate 1
• Enalapril: Target dose 10 mg twice daily (20 mg total daily); start 2.5 mg twice daily 1
• Ramipril: Target dose 10 mg daily; start 1.25–2.5 mg once daily 1

Beta-Blockers

• Carvedilol: Target dose 25 mg twice daily (50 mg total); start 3.125 mg twice daily 1
• Metoprolol succinate: Target dose 200 mg daily; start 12.5–25 mg once daily 1
• Bisoprolol: Target dose 10 mg daily; start 1.25 mg once daily 1

Aldosterone Antagonists

• Spironolactone:
  • eGFR ≥50 mL/min: Start 12.5–25 mg daily; target 25 mg once or twice daily 1
  • eGFR 30–49 mL/min: Start 12.5 mg daily or every other day; target 12.5–25 mg daily 1
• Eplerenone:
  • eGFR ≥50 mL/min: Start 25 mg daily; target 50 mg daily 1
  • eGFR 30–49 mL/min: Start 25 mg every other day; target 25 mg daily 1

Pain Management (Neuropathic Pain)

Gabapentin

• Creatinine clearance >60 mL/min: Start 100–300 mg at bedtime or three times daily; titrate to maximum 3600 mg/day in divided doses 1
• Renal impairment: Reduce dose proportionally to creatinine clearance 1

Pregabalin

• Normal renal function: Start 50 mg three times daily or 75 mg twice daily; maximum 600 mg/day 1
• Renal impairment: Reduce dose based on creatinine clearance 1

Critical Timing Principles

Always administer dialyzable medications immediately after hemodialysis sessions, never before, as pre-dialysis dosing results in immediate drug removal and subtherapeutic levels. 3, 4 This applies to:

• All beta-lactam antibiotics 3, 4
• Fluoroquinolones 3, 4
• Vancomycin 4
• Aminoglycosides 1

Therapeutic Drug Monitoring

For narrow therapeutic index drugs in renal impairment, measure serum concentrations to verify adequate exposure while preventing toxicity:

• Vancomycin: Pre-dialysis trough before 3rd or 4th dose 4
• Aminoglycosides: Peak and trough levels 1
• Cephalexin in ESRD: Serum levels at 2 and 6 hours post-dose 3

Common Pitfalls to Avoid

Never use daily dosing intervals for dialyzable drugs in hemodialysis patients—this causes toxic accumulation. 4 The correct approach is thrice-weekly dosing after dialysis. 3, 4

Never reduce individual dose sizes in renal impairment for concentration-dependent antibiotics (fluoroquinolones, aminoglycosides)—this produces treatment failure. 3, 4 Instead, extend the dosing interval while maintaining full doses. 1, 3

Avoid aminoglycosides as first-line therapy in hemodialysis patients due to substantial risk of irreversible ototoxicity. 3 If unavoidable, use intermittent dosing (2–3 times weekly after dialysis) with mandatory therapeutic drug monitoring. 1

Special Populations Requiring Modified Dosing

Elderly Patients (>59 years)

• Streptomycin/Amikacin: Reduce dose to 10 mg/kg/day (maximum 750 mg) 1
• Amantadine: Maximum 100 mg daily for prophylaxis or treatment 1
• Rimantadine: 100 mg daily for prophylaxis; 200 mg daily for treatment (reduce to 100 mg if side effects) 1

Hepatic Impairment

• Clarithromycin, rifabutin, isoniazid: Use with caution 1
• Trimethoprim-sulfamethoxazole: Use with caution 1
• Tigecycline: Reduce to 25 mg once or twice daily in severe hepatic impairment 1

Pregnancy

• Streptomycin: Contraindicated due to fetal hearing loss risk 1
• Doxycycline: Contraindicated (pregnancy category D) 5

Algorithm for Dose Selection

1. Calculate creatinine clearance using Cockcroft-Gault formula 2
2. Identify if drug is renally eliminated (>30% unchanged in urine requires adjustment) 2
3. For hemodialysis patients:
   • Use full individual dose 1, 3, 4
   • Extend interval to after each dialysis session (typically 3×/week) 3, 4
   • Never dose before dialysis 3, 4
4. For non-dialysis renal impairment:
   • Maintain dose, extend interval for concentration-dependent drugs 1, 3
   • Reduce dose proportionally for time-dependent drugs 1
5. Implement therapeutic drug monitoring for narrow therapeutic index agents 4, 2